Cargando…
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
BACKGROUND: Primary and recurrent giant cell tumor of bone is typically benign; however, rarely giant cell tumor of bone can undergo malignant transformation. Malignancy in giant cell tumor of bone may be primary (adjacent to benign giant cell tumor of bone at first diagnosis) or secondary (at the s...
Autores principales: | Palmerini, Emanuela, Picci, Piero, Reichardt, Peter, Downey, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446439/ https://www.ncbi.nlm.nih.gov/pubmed/30935298 http://dx.doi.org/10.1177/1533033819840000 |
Ejemplares similares
-
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
por: Palmerini, Emanuela, et al.
Publicado: (2021) -
Rare Primary Malignant Bone Sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2020) -
Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?
por: Maros, Mate E., et al.
Publicado: (2021) -
Malignancy in giant cell tumor of bone in the extremities
por: Liu, Weifeng, et al.
Publicado: (2020) -
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
por: Morii, Rokuro, et al.
Publicado: (2021)